Efficacy of Anti-Toxoplasma Medications in Symptom Severity and Cognition in Patients with Schizophrenia or Schizoaffective Disorder: Systematic Review and Meta-analysis
Anti-Toxoplasma antibiotics may offer potential benefits as adjunctive therapy for schizophrenia. However, heterogeneity and methodological limitations complicate conclusions. Large-scale RCTs are needed further to clarify the role of anti-Toxoplasma antibiotics in schizophrenia treatment.
Authors
- Germán Mejía‐Salgado (ORCID: https://orcid.org/0000-0002-1241-0715)
- Alejandra de‐la‐Torre (ORCID: https://orcid.org/0000-0003-0684-1989)
- Daniela Alejandra Cusicanqui Méndez (ORCID: https://orcid.org/0000-0002-6648-6141)
- Andrés Sánchez Sarmiento
- Juan Fernando Cano (ORCID: https://orcid.org/0000-0003-4087-9534)
- Bibiana Briceño
- Sebastián Galindo-Pita
Institutions
- Universidad del Rosario (CO)
Publication Details
- Journal
- Brazilian Journal of Psychiatry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.47626/1516-4446-2025-4185
- Primary Topic
- Toxoplasma gondii Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00